Sweetening pharmaceutical radiochemistry by (18)f-fluoroglycosylation: a short review

Biomed Res Int. 2014:2014:214748. doi: 10.1155/2014/214748. Epub 2014 Jun 1.


At the time when the highly efficient [(18)F]FDG synthesis was discovered by the use of the effective precursor 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl- β -D-mannopyranose (mannose triflate) for nucleophilic (18)F-substitution, the field of PET in nuclear medicine experienced a long-term boom. Thirty years later, various strategies for chemoselective (18)F-labeling of biomolecules have been developed, trying to keep up with the emerging field of radiopharmaceutical sciences. Among the new radiochemical strategies, chemoselective (18)F-fluoroglycosylation methods aim at the sweetening of pharmaceutical radiochemistry by providing a powerful and highly valuable tool for the design of (18)F-glycoconjugates with suitable in vivo properties for PET imaging studies. This paper provides a short review (reflecting the literature not older than 8 years) on the different (18)F-fluoroglycosylation reactions that have been applied to the development of various (18)F-glycoconjugate tracers, including not only peptides, but also nonpeptidic tracers and high-molecular-weight proteins.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Fluorodeoxyglucose F18* / chemistry
  • Humans
  • Nuclear Medicine / methods
  • Peptides
  • Positron-Emission Tomography*
  • Radiochemistry*
  • Radiopharmaceuticals* / chemistry


  • Peptides
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18